SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000912282-24-000130
Filing Date
2024-02-07
Accepted
2024-02-07 17:26:13
Documents
1
Period of Report
2024-02-05

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3709
  Complete submission text file 0000912282-24-000130.txt   5510
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Issuer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O APTOSE BIOSCIENCES INC. 2511 CONSUMERS ROAD, SUITE 1105 TORONTO A6 M2J 4R3
Business Address
LEDRU PHILIPPE (Reporting) CIK: 0001923073 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32001 | Film No.: 24605931